Mallinckrodt PLC
MNK
Delayed Nyse - 11/17 10:01:40 pm
22.38USD
-0.31%
Prev.22.4500
Open22.2300
High22.5800
Low21.9100
Volume2 570 127
Last news
Financials
Sales 2017 3 266 M
EBIT 2017 1 199 M
R. net 2017 432 M
Debt 2017 5 195 M
Rend. 2017 -
P/E ratio 2017 8,30
P/E ratio 2018 8,66
EV / Sales 2017 2,24x
EV / Sales 2018 2,12x
Capitalization 2 126 M
Company
Mallinckrodt Plc operates as a global specialty pharmaceuticals company.It develops, manufactures, markets and distributes both branded and generic specialty pharmaceutical products and medical imaging agents.It operates through the following segments: Specialty Brands, Specialty Generics, and...
Sector :
Specialty & Advanced Pharmaceuticals
Calendar :
2017-12-14 Presentation
Trading Rating :
Investor Rating :
Technical analysis trends
Short TermMid-TermLong Term
TrendBearishBearishBearish
Resistance26,732,137,4
Spread/Res.-16%-30%-40%
Spread/Supp.12%12%2,8%
Support20,020,021,8